Skip to main content
You're viewing the free public version. Create a free account for full research and member tools. Join free
Research Abstract Human Study

Daily supplementation with Aronia fruit extract significantly improves cardiovascular health markers and reduces inflammation and oxidative stress.

Aronia (Chokeberry) Fruit Extract is a Potential Candidate for Managing Metabolic Syndrome in Elderly Patients.

0:00 / 0:00
0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

283 views
Share:

Abstract

OBJECTIVES: Natural products like Aronia () are promising candidates to manage metabolic abnormalities due to their bioactive compounds. This study aimed to evaluate the effects of daily Aronia fruit extract supplementation on the components of Metabolic Syndrome (MetS), cardiovascular health, inflammation, and atherogenic markers in elderly patients. METHODS: Our study is a randomized controlled trial of 44 subjects (12 males and 32 females) diagnosed with MetS. The study groups were the intervention group ( = 22), which received daily 10 g Aronia fruit extract for 8 wk, and the control group, which did not receive the extract ( = 22). Demographics, dietary intake, and food habits were recorded by an extended survey. Baseline and post-intervention measurements of anthropometric data, dietary intake, cardiovascular parameters, blood pressure, blood lipid composition, plasma atherogenic index (PAI), triglyceride (TG), and the triglyceride-glucose index (TyG), and biomarkers of inflammation, including tumor necrosis factor-alpha (TNF-α), Interleukin 6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and oxidative stress biomarkers, were represented as delta values. RESULTS: No significant changes were observed in anthropometric measurements within or between groups over the 8 wk. However, several cardiovascular health parameters, including diastolic blood pressure (-10.00 mmHg), PAI index (-0.06), triglycerides (-9.0 mg/dL), and low-density lipoprotein cholesterol (LDL-C) (-6.30 mg/dL) were significantly decreased in the intervention group compared to the control group at the end of 8 wk of use ( 

Affiliation

Pelin Baltacı

External References

PubMed ID:
40905799

Comments

Sign in or create a free account to join the conversation.

Sign in to comment

Be the first to comment.

Trusted By Professionals and Teams:

The National Health Federation
Stand For Health Freedom
Global Healing Institute
Global Wellness Forum
MAHA Action
Myers Detox
Natural News
Mercola.com

Unlock Evidence-Based Health Research

Join 500,000+ members accessing 10,000+ natural health topics.

Subscribe to our informative Newsletter & Receive

Cancer Fighting Foods Ebook

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.